OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Wei Yu, Jidong Cheng
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 247
Wei Yu, Jidong Cheng
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 247
Showing 26-50 of 247 citing articles:
Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies
Yingli Lu, Ying Sun, Lingli Cai, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 6
Yingli Lu, Ying Sun, Lingli Cai, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 6
Hyperuricemia, Gout, and the Brain—an Update
Augustin Latourte, Julien Dumurgier, Claire Paquet, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Augustin Latourte, Julien Dumurgier, Claire Paquet, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics
Nankun Qin, Ming Qin, Wenjun Shi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Nankun Qin, Ming Qin, Wenjun Shi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom
Mark Russell, Andrew I Rutherford, Benjamin Ellis, et al.
The Lancet Regional Health - Europe (2022) Vol. 18, pp. 100416-100416
Open Access | Times Cited: 26
Mark Russell, Andrew I Rutherford, Benjamin Ellis, et al.
The Lancet Regional Health - Europe (2022) Vol. 18, pp. 100416-100416
Open Access | Times Cited: 26
Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis
Xiangming Hu, Jieliang Liu, Wei Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 7, pp. 1661-1669
Closed Access | Times Cited: 25
Xiangming Hu, Jieliang Liu, Wei Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 7, pp. 1661-1669
Closed Access | Times Cited: 25
Relation Between Serum Uric Acid to Albumin Ratio and Severity of Chronic Coronary Artery Disease
Damla Yalçınkaya, Kadir Karacali, Bilal Canberk Ilhan, et al.
Angiology (2023) Vol. 75, Iss. 4, pp. 386-393
Closed Access | Times Cited: 14
Damla Yalçınkaya, Kadir Karacali, Bilal Canberk Ilhan, et al.
Angiology (2023) Vol. 75, Iss. 4, pp. 386-393
Closed Access | Times Cited: 14
Association of hyperuricemia with cardiovascular diseases: current evidence
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
Michel Burnier
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Michel Burnier
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways
Adelina Curaj, Raymond Vanholder, Joseph Loscalzo, et al.
Circulation Research (2024) Vol. 134, Iss. 5, pp. 592-613
Closed Access | Times Cited: 5
Adelina Curaj, Raymond Vanholder, Joseph Loscalzo, et al.
Circulation Research (2024) Vol. 134, Iss. 5, pp. 592-613
Closed Access | Times Cited: 5
U-shaped relationship between uric acid levels and all-cause mortality in patients with hypertension
Yating Huang, Jie Li, Feifei Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yating Huang, Jie Li, Feifei Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The potential of the serum uric acid to high-density lipoprotein cholesterol ratio as a predictive biomarker of diabetes risk: a study based on NHANES 2005–2018
Jianming Yin, Caixia Zheng, Xiaoqian Lin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Jianming Yin, Caixia Zheng, Xiaoqian Lin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
The role of hyperuricemia in the progression of end‐stage kidney disease and its molecular prospective in inflammation and cardiovascular diseases: A general review
Yasir Waheed, Jie Liu, Shifaa Almayahe, et al.
Therapeutic Apheresis and Dialysis (2025)
Closed Access
Yasir Waheed, Jie Liu, Shifaa Almayahe, et al.
Therapeutic Apheresis and Dialysis (2025)
Closed Access
Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction
Jialiang Zhang, Wenhua Lei, Jing Zhou, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Closed Access
Jialiang Zhang, Wenhua Lei, Jing Zhou, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Closed Access
Inosine from purine metabolism enhances fracture healing by coupling fibrinolysis and angiogenesis of type H vessels
Guan-Lin Lee, Chih-Chien Hu, Meifeng Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167818-167818
Closed Access
Guan-Lin Lee, Chih-Chien Hu, Meifeng Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167818-167818
Closed Access
Silencing TXNIP ameliorates high uric acid-induced insulin resistance via the IRS2/AKT and Nrf2/HO-1 pathways in macrophages
Wei Yu, Chunjuan Chen, Wanling Zhuang, et al.
Free Radical Biology and Medicine (2021) Vol. 178, pp. 42-53
Closed Access | Times Cited: 31
Wei Yu, Chunjuan Chen, Wanling Zhuang, et al.
Free Radical Biology and Medicine (2021) Vol. 178, pp. 42-53
Closed Access | Times Cited: 31
The number of risk factors increases the recurrence events in ischemic stroke
Cep Juli, Henhen Heryaman, Arnengsih, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Cep Juli, Henhen Heryaman, Arnengsih, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Relationship between hyperuricemia with deposition and sexual dysfunction in males and females
Andrea Sansone, Yacov Reisman, Emmanuele A. Jannini
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 4, pp. 691-703
Open Access | Times Cited: 21
Andrea Sansone, Yacov Reisman, Emmanuele A. Jannini
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 4, pp. 691-703
Open Access | Times Cited: 21
Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2353-2353
Open Access | Times Cited: 12
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2353-2353
Open Access | Times Cited: 12
The combination of high uric acid and high C-reactive protein increased the risk of cardiovascular disease: A 15-year prospective cohort study
Na Li, Shouling Wu, Rong Shu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 6, pp. 1508-1517
Closed Access | Times Cited: 4
Na Li, Shouling Wu, Rong Shu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 6, pp. 1508-1517
Closed Access | Times Cited: 4
Uric acid and cardiovascular diseases: a reappraisal
Akruti Patel Prabhakar, Angel López‐Candales
Postgraduate Medicine (2024) Vol. 136, Iss. 6, pp. 615-623
Closed Access | Times Cited: 4
Akruti Patel Prabhakar, Angel López‐Candales
Postgraduate Medicine (2024) Vol. 136, Iss. 6, pp. 615-623
Closed Access | Times Cited: 4
Exploring gene expression, alternative splicing events and RNA-binding proteins changes in PBMC from patients with hyperuricemia
Xuanxia Wu, Juan Bu, Xianli Niu, et al.
Gene (2025), pp. 149256-149256
Closed Access
Xuanxia Wu, Juan Bu, Xianli Niu, et al.
Gene (2025), pp. 149256-149256
Closed Access
Correlation between serum uric acid to high-density lipoprotein cholesterol ratio and cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study
Shiyang Li, Yanyu Zhang, Deyun Luo, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103865-103865
Closed Access
Shiyang Li, Yanyu Zhang, Deyun Luo, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103865-103865
Closed Access
Exploring the prevalence of gout among underrepresented low socioeconomic status type 2 diabetes populations
Jessica Smith, Abey Martin, Jane Mundadan, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Jessica Smith, Abey Martin, Jane Mundadan, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH
Louise E. van Eekeren, Nadira Vadaq, Marc J. T. Blaauw, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Louise E. van Eekeren, Nadira Vadaq, Marc J. T. Blaauw, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Management of gout in primary care of Hong Kong in accordance with international guidelines: any gaps to bridge?
K. Chan, Lapkin Chiang, Khek Yu Ho, et al.
BMC Primary Care (2025) Vol. 26, Iss. 1
Open Access
K. Chan, Lapkin Chiang, Khek Yu Ho, et al.
BMC Primary Care (2025) Vol. 26, Iss. 1
Open Access
